13 Jul '23 at 6:52 pm #62093
Participant
Theseus Pharmaceuticals (THRX) to Discontinue Enrollment in Phase 1/2 Study and Terminate Development of THE-630 in Patients with GIST…
THRX down 73.7%
Where Independent Traders, Investors, and Dribblers Thrive
Theseus Pharmaceuticals (THRX) to Discontinue Enrollment in Phase 1/2 Study and Terminate Development of THE-630 in Patients with GIST…
THRX down 73.7%
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |